Bucillamine April 10, 2017 Bucillamine Trade Name Orphan Indication Cystinuria USA Market Approval USA USA Designation Date 2015-10-22 00:00:00 Sponsor Revive Therapeutics, Ltd.;5 Director Court, Suite 105;Vaughan, Ontario
